Search Within

Gabriella D'Andrea-Carlino

  1. "Biostatistics Service"
Formats
  1. Journal Article (24)
  2. Meeting Abstract (24)
Groups
  1. Biostatistics Service (48)
  2. Breast Medicine Service (48)
  3. Department of Medicine (48)
  4. Epidemiology and Biostatistics (48)
  5. Solid Tumor Oncology Division (48)
  6. Survivorship Research (48)

More Groups

People
  1. Clifford Hudis (45)
  2. Larry Norton (32)
  3. Diana Lake (29)
  4. Sujata Patil (27)
  5. Monica Fornier (26)
  6. Shanu Modi (23)

More People

Years
  1. 2023 (1)
  2. 2020 (1)
  3. 2018 (1)
  4. 2017 (1)
  5. 2016 (2)
  6. 2015 (4)

More Years

Publications
  1. Journal of Clinical Oncology (12)
  2. Cancer Research (9)
  3. Clinical Cancer Research (8)
  4. Breast Cancer Research and Treatment (7)
  5. Clinical Breast Cancer (6)
  6. Journal of the American Geriatrics Society (2)

More Publications

Publishers
  1. American Association for Cancer Research (17)
  2. American Society of Clinical Oncology (12)
  3. Springer (7)
  4. Elsevier Inc. (6)
  5. Oxford University Press (2)
  6. Wiley Blackwell (2)

More Publishers

Results (48)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase II trial of erlotinib in combination with bevacizumab in patients with metastatic breast cancer
    Journal Article

    Dickler, M. N.; Rugo, H. S.; Eberle, C.; Brogi, E.; Caravelli, J.; Panageas, K. S.; Boyd, J.; Yeh, B.; Lake, D. E.; Dang, C.; more...
    Clinical Cancer Research (2008)

    Fulltext@MSK | Save
  • The safety of dose-dense doxorubicin and cyclophosphamide followed by paclitaxel with trastuzumab in HER-2/neu overexpressed/amplified breast cancer
    Journal Article

    Dang, C.; Fornier, M.; Sugarman, S.; Troso-Sandoval, T.; Lake, D.; D'Andrea, G.; Seidman, A.; Sklarin, N.; Dickler, M.; Currie, V.; more...
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Prolonged dose-dense epirubicin and cyclophosphamide followed by paclitaxel in breast cancer is feasible
    Journal Article

    Dang, C.; D'Andrea, G.; Lake, D.; Sugarman, S.; Fornier, M.; Moynahan, M. E.; Gilewski, T.; Hurria, A.; Mills, N.; Troso-Sandoval, T.; more...
    Clinical Breast Cancer (2008)

    Fulltext@MSK | Save
  • Increased dose density is feasible: A pilot study of adjuvant epirubicin and cyclophosphamide followed by paclitaxel, at 10- or 11-day intervals with filgrastim support in women with breast cancer
    Journal Article

    Fornier, M. N.; Seidman, A. D.; Lake, D.; D'Andrea, G.; Bromberg, J.; Robson, M.; Van Poznak, C.; Panageas, K. S.; Atienza, M.; Norton, L.; more...
    Clinical Cancer Research (2007)

    Fulltext@MSK | Save
  • A pilot study of growth factor (GF) omission during paclitaxel (T) for women with early breast carcinoma (BC)
    Meeting Abstract

    Sugarman, S. M.; Wasserheit, C.; Hodgman, E.; Coglianese, M. E.; D'alessandro, A.; Fornier, M.; Troso-Sandoval, T.; D'Andrea, G.; Drullinsky, P.; Lake, D.; more...
    Breast Cancer Research and Treatment (2006)

    Fulltext@MSK | Save
  • A prospective, longitudinal study of the functional status and quality of life of older patients with breast cancer receiving adjuvant chemotherapy
    Journal Article

    Hurria, A.; Zuckerman, E.; Panageas, K. S.; Fornier, M.; D'Andrea, G.; Dang, C.; Moasser, M.; Robson, M.; Seidman, A.; Currie, V.; more...
    Journal of the American Geriatrics Society (2006)

    Fulltext@MSK | Save
  • Cognitive function of older patients receiving adjuvant chemotherapy for breast cancer: A pilot prospective longitudinal study
    Journal Article

    Hurria, A.; Rosen, C.; Hudis, C.; Zuckerman, E.; Panageas, K. S.; Lachs, M. S.; Witmer, M.; Van Gorp, W. G.; Fornier, M.; D'Andrea, G.; more...
    Journal of the American Geriatrics Society (2006)

    Fulltext@MSK | Save
  • Pharmacokinetics and toxicity of weekly docetaxel in older patients
    Journal Article

    Hurria, A.; Fleming, M. T.; Baker, S. D.; Kelly, Wm K.; Cutchall, K.; Panageas, K.; Caravelli, J.; Yeung, H.; Kris, M. G.; Gomez, J.; more...
    Clinical Cancer Research (2006)

    Fulltext@MSK | Save
  • A prospective longitudinal study of the impact of adjuvant chemotherapy for breast cancer (BC) on older patients' functional status and quality of life
    Meeting Abstract

    Hurria, A.; Panageas, K.; Zuckerman, E.; Fornier, M.; D'Andrea, G.; Dang, C.; Moasser, M.; Robson, M.; Seidman, A.; Currie, V.; more...
    Breast Cancer Research and Treatment (2005)

    Fulltext@MSK | Save
  • Increased dose-density (DD) is feasible: A pilot study of epirubicin and cyclophosphamide (EC) followed by paclitaxel (T), at 10-11 day interval with filgrastim support, for women with early breast carcinoma (BC)
    Meeting Abstract

    Fornier, M. N.; Seidman, A. D.; Lake, D.; D'Andrea, G.; Bromberg, J.; Robson, M.; Van Poznak, C. H.; Panageas, K.; Norton, L.; Hudis, C.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save